Clinical Trial Update: Prophylactic Enoxaparin Dosing in Roux-en-Y Gastric Bypass Surgery Patients at St. Vincent Carmel

View source ↗

Summary

This clinical trial update summarizes the completed study on prophylactic enoxaparin dosing in Roux-en-Y gastric bypass patients at St. Vincent Carmel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Lovenox (enoxaparin)

Snippet

Sponsor: Ascension St. Vincent Carmel Hospital | Conditions: Obesity | Status: COMPLETED